Introduction
Status epilepticus (SE) is considered a neurological emergency with a high degree of mortality. 1 Twelve to 30% of adult patients with temporal lobe Seizure (2007) Summary The effect of 8-OH-DPAT, a 5-HT 1A receptor agonist, on electrographic activity during the kainic acid (KA)-induced status epilepticus (SE) was evaluated in male Wistar rats. Electrographic (EEG) recordings from the ventral hippocampus and the frontal cortex along with behavioral changes were evaluated in animals that received KA administration (10 mg/kg, i.p.) 20 min after saline solution (control group) or 8-OH-DPAT (1 mg/kg, s.c.) injection. Rats pretreated with 8-OH-DPAT presented augmented latency for wet dog shakes (71%), generalized seizures (54%) and behavioral SE (31%). 8-OH-DPAT delayed occurrence of the first KA-induced paroxystic spikes (70%), increased latency to the EEG SE (39%) and decreased spike frequency (35-43%) recorded from the frontal cortex, and increased the time necessary for the high voltage EEG activity synchronization of the hippocampus and the frontal cortex (125%). However, EEG ictal activity recorded in hippocampus was not modified after 8-OH-DPAT pretreatment. These results indicate that 8-OH-DPAT reduces the EEG activity associated with the KA-induced SE in the frontal cortex, but not the hippocampus, and suggest an inhibitory effect in the propagation of epileptic seizures during the KA-induced SE. epilepsy present SE during infancy. 2, 3 The fundamental pathophysiology of SE involves a failure of mechanisms that normally abort an isolated seizure. This failure can arise from abnormally persistent, excessive excitation or ineffective recruitment of inhibition. 1 Kainic acid (KA) produces SE of limbic seizures by activation of glutamatergic receptors localized in high density in the hippocampus. [4] [5] [6] After systemic injection of KA, it has been considered that the hippocampus becomes the primary epileptic focus and thereafter, the seizure activity propagates to limbic and extralimbic brain areas including the cortex. 4, 5, 7, 8 On the other hand, serotonin (5-HT) has been involved in many cerebral disorders including epilepsy. 9 The activation of 5-HT 1A receptors reduces the in vitro epileptiform activity. [10] [11] [12] [13] [14] The in vivo administration of 5-HT 1A receptor agonists, such as 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), increases the after discharge threshold, reduces the duration of partial seizures and avoids the progression and generalization of partial seizures induced by electrical kindling. [15] [16] [17] 8-OH-DPAT also decreases the number and duration of KA-induced hippocampal electrographic seizures 18 and increases the latency to the wet dog shakes (WDS), generalized seizures (GS) and occurrence of SE 19 by activation of 5-HT 1A receptors.
The hippocampus and frontal cortex present a high density of 5-HT 1A receptors 20, 21 and the activation of these receptors may differentially modulate the participation of these brain areas in the generation and/or the propagation of epileptic activity during KA-induced SE. The main goal of the present study was to analyze how 8-OH-DPAT modulates the KA-induced electrographic (EEG) seizures in the hippocampus and frontal cortex, considered as the epileptic focus and the area of seizure propagation, respectively.
Methods

Subjects
Male Wistar rats, initially weighing 300 g, housed at 22 8C and maintained on 12-h light/12-h dark cycles were used in the present study. The animals had free access to food and water. Procedures involving the animals' care were conducted in agreement with the ''Norma Oficial Mexicana'' (NOM-062-ZOO-1999) and the Ethical Committee of the ''Centro de Investigación y de Estudios Avanzados'' (Project 222/04).
Experimental groups
Rats were anesthetized with a combination of Ketamine (100 mg/kg, i.p., Ketalin 1 from Probiomed) and Xylazine (20 mg/kg, i.m., Sigma). Then, a bipolar electrode, consisting of two twisted strands of stainless steel wire, insulated except at the crosssection of their tips, was stereotaxically implanted into the CA1 field of the right ventral hippocampus. Coordinates in millimeters were as follows: 5.6 caudal to bregma, 4.6 from the midsagittal plane and 8.0 from the skull surface. 22 The electrode was attached to male connector pins, which were inserted into a connector strip. Stainless steel screws were threaded into the cranium over the right and left frontal cortex to fix the electrode assembly and to record the EEG activity. The electrode assembly was then fixed to the skull with dental acrylic. The animals were kept individually in plastic cages. One week after surgery, the rats received saline solution (SS, 1 ml/kg, s.c.; n = 6) or 8-OH-DPAT (Sigma; 1 mg/kg, s.c.; n = 6) and 20 min after, they received KA (10 mg/kg, i.p.) administration. EEG from the ventral hippocampus and frontal cortex was recorded using a Grass model 8-18D EEG machine. EEG was continuously obtained in basal conditions (5 min before the SS or 8-OH-DPAT injection) and during 3 h after KA injection.
The following parameters on behavior and EEG recording were obtained in accordance with previous studies 18, 19, 23 : (a) latency to the first WDS, the first behavioral GS and the behavioral SE, (b) latency to the synchronization of high voltage EEG activity between ventral hippocampus and frontal cortex, (c) latency to the first EEG seizure (high amplitude discharges lasting at least 3 s), (d) latency to the establishment of electrographic SE (continuous polyspike activity), (e) total time spent in EEG seizure activity (cumulative seizure time subtracting interictal time), and (f) spike frequency (spikes per second). For spike evaluation, the amplitude threshold was set at least three times baseline.
The spike frequency was calculated every 15 min during the first hour after KA administration and then, every 30 min during the last 2 h. Correlations between the spike frequency and time course were obtained and then, the area under the curve (AUC) was calculated by the trapezoidal rule. 24 Preliminary experiments from our lab revealed that the time course of the spike frequency consisted of two phases as follows: (a) phase I (from 0 to 60 min after KA) that comprises the onset and propagation of ictal activity and (b) phase II (from 60 to 180 min after KA), that represents the appearance and maintenance of the SE.
At the end of the experiments, animals received an overdose of pentobarbital and they were killed by decapitation. The brain were removed and frozen coronal sections (20 mm) were obtained and then stained with cresyl violet to verify electrode implantation by light microscopy.
Statistical analysis
Results were analyzed with an unpaired one-tailed Student's t test using GraphPad Prism software TM Version 4.00 for Windows, and significances were assigned at the 0.05 level.
Results
Administration of 10 mg/kg KA-induced WDS, GS and SE in all animals (100%) pretreated with SS and 8-OH-DPAT. Behavioral recordings revealed that rats pretreated with SS showed the first WDS at 23.8 AE 3.3 min, the first GS at 72.2 AE 5.9 min and the SE at 96.1 AE 6.9 min after KA injection. Animals pretreated with 8-OH-DPAT displayed augmented latency for the WDS (40.7 AE 4.7 min, 71%; p < 0.01), the GS (110.9 AE 7.1 min, 54%; p < 0.001) and the SE (125.4 AE 6.6 min, 31%; p < 0.01), when compared with the KA control group.
The histological evaluation revealed that the implanted electrodes were located in the CA1 field of the ventral hippocampus and frontal cortex in all rats. EEG recordings showed that rats pretreated with 8-OH-DPAT displayed augmented latency to the onset of epileptic spikes in the frontal cortex (70%), but not in the hippocampus, in contrast to the control animals. However, latency to the first EEG seizure was not modified in the hippocampus or in the frontal cortex. The latency for the KA-induced high voltage EEG activity synchronization of the hippocampus and the frontal cortex was significantly increased (125%) in rats that received 8-OH-DPAT. With regard to the latency to the EEG SE, animals pretreated with 8-OH-DPAT showed increased values for frontal cortex recordings (39%), but no significant changes for hippocampus. Nevertheless, the total time spent in EEG ictal activity recorded in the hippocampus and the frontal cortex was not significantly different after 8-OH-DPAT pretreatment when compared with KA control animals ( Table 1) .
Rats pretreated with 8-OH-DPAT showed reduced KA-induced spike frequency in frontal cortex, as it was observed on the decreased AUC for phase I (43%) Effect of 8-OH-DPAT on KA-induced SE 367 and phase II (35%), when compared with SS pretreated animals. However, this effect was not detected in EEG recordings from the hippocampus ( Figs. 1 and 2 ).
Discussion
In the present study, the effects of 8-OH-DPAT, a 5-HT 1A receptor agonist, were evaluated in the behavioral and EEG activity during the SE of limbic seizures induced by KA. The results obtained indicate that 8-OH-DPAT produces differential effects in hippocampal and cortical epileptiform activity. Systemic administration of 8-OH-DPAT increased the latency to the behavioral WDS, GS and SE induced by systemic KA injection. These effects correlate with decreased KA-induced epileptic EEG activity. The results obtained support a decreased severity of KA-induced behavioral seizures after 8-OH-DPAT treatment, such has been previously indicated. 19 Previous studies have indicated that activation of 5-HT 1A receptors from the hippocampus and the frontal cortex reduces the EEG epileptiform activity when induced in vitro 10, 12, 13 and in vivo. 15, 16, 18 The present study demonstrates that systemic administration of 8-OH-DPAT produces a delay in the EEG appearance of KA-induced first epileptiform spike and SE in the frontal cortex, indicating a delay in the onset of the convulsive action of KA. Additionally, 8-OH-DPAT enhanced the time necessary to synchronize the high voltage EEG activity between the hippocampus and frontal cortex and decreased the frequency of epileptic spikes recorded in the frontal cortex. These results suggest an inhibitory action of 5-HT 1A receptors in the frontal cortex and a protective effect of 8-OH-DPAT in this brain area against KAinduced SE. In contrast, the KA-induced epileptic activity from ventral hippocampus was not modified by 8-OH-DPAT. The ventral hippocampus has elevated susceptibility to epileptic activity, including a low threshold to epileptiform afterdischarges 25 and a high susceptibility to the KA-induced excitatory effects. 26, 27 It seems that the activation of 5-HT 1A receptors by 8-OH-DPAT is not sufficient to modify the KA-induced epileptiform activity and occurrence of SE in this brain area. Given this evidence, it is possible that the effects induced by 8-OH-DPAT are not strong enough to modify the epileptic activity in the epileptic focus (ventral hippocampus), but do decrease the epileptic activity in surrounding areas (frontal cortex). This effect is relevant considering that neocortical, but not hippocampal, electrographic changes correlated with development of convulsive behaviors caused by KA. 28 In addition, the frontal cortex is involved in the processes of seizure propagation and synchronization. [29] [30] [31] [32] [33] [34] In fact, the neocortex may exert contralateral inhibitory influences, via the corpus callosum after systemic KA injection. 35 The delayed appearance and reduced high voltage EEG activity in the frontal cortex induced by 8-OH-DPAT could be explained by a low synchronization between the hippocampus and frontal cortex with a consequent reduction in the epileptic activity. However, further experiments are necessary to investigate this hypothesis.
In this study, the analysis of spike frequency progression during the KA-induced SE revealed the initiation and maintenance phases previously described through the SE induced by pilocarpine and self sustained-SE. [36] [37] [38] [39] In these models, the initiation phase depends on the presence of external stimulus (i.e., pilocarpine or electrical stimulation) and is characterized by a progressive increase of the spike frequency, whereas the maintenance phase comprises seizures that occur after the external stimulation is discontinued and involves mechanisms of maintenance of SE during which the spike frequency becomes constant. 37, 40 The knowledge of mechanisms associated with these two phases may be important to investigate different pharmacological profiles of the initiation and maintenance phases of KA-induced SE. Our results revealed that 8-OH-DPAT decreased the spike frequency during the initiation and maintenance phases in the frontal cortex, an effect not detected in hippocampus. The important consideration of these findings is a stronger inhibitory effect of 8-OH-DPAT in the propagation of the epileptic activity in the cortex at the beginning of KA-induced epileptiform activity.
In conclusion, 8-OH-DPAT reduces the EEG activity during the KA-induced SE in the frontal cortex, which correlates with a reduction in convulsive behavior, an effect that may involve a reduced propagation but not generation of epileptic activity. Since 8-OH-DPAT was systemically applied, we cannot disregard that 5-HT 1A receptor activation in other brain areas, such as the amygdala, thalamus and brain stem nuclei, or serotonergic projections may be involved in the effects found in the present study. These results encourage the study of 5-HT 1A receptor agonists alone or in combination with classical antiepileptic drugs as new therapeutic strategies to control SE.
